What companies are XPH's competitors?

State Street SPDR S&P Pharmaceuticals ETF (XPH)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does XPH compare to its peers?

The peer comparison table on this page shows State Street SPDR S&P Pharmaceuticals ETF (XPH) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does XPH operate in?

State Street SPDR S&P Pharmaceuticals ETF (XPH) operates in the Asset Management industry within the Financial Services sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

XPH

State Street SPDR S&P Pharmaceuticals ETF

AMEX·Asset Management · Financial Services

$68.49$0.44+0.65%

After hours·$68.29−0.29%

Market cap$276.21M·Market closed·Jul 23 8:00 PM UTC

Frequently Asked Questions About XPH

What companies are XPH's competitors?: State Street SPDR S&P Pharmaceuticals ETF (XPH)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does XPH compare to its peers?: The peer comparison table on this page shows State Street SPDR S&P Pharmaceuticals ETF (XPH) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does XPH operate in?: State Street SPDR S&P Pharmaceuticals ETF (XPH) operates in the Asset Management industry within the Financial Services sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

XPH

State Street SPDR S&P Pharmaceuticals ETF

AMEX·Asset Management · Financial Services

$68.49$0.44+0.65%

After hours·$68.29−0.29%

Market cap$276.21M·Market closed·Jul 23 8:00 PM UTC

Peers


XES	State Street SPDR S&P Oil & Gas Equipment & Services ETF	$115.77	$258.8M
TBG	TBG Dividend Focus ETF	$37.35	$237.9M
BFOR	Barron's 400SM ETF	$23.40	$229.8M
XTL	State Street SPDR S&P Telecom ETF	$213.13	$229.4M
HSCZ	iShares Currency Hedged MSCI EAFE Small-Cap ETF	$42.86	$222.6M
DEUS	Xtrackers Russell US Multifactor ETF	$66.07	$202.1M
TUR	iShares MSCI Turkey ETF	$39.77	$199.7M
XTN	State Street SPDR S&P Transportation ETF	$115.22	$176.5M
SDG	iShares MSCI Global Sustainable Development Goals ETF	$88.07	$169.4M
DFE	WisdomTree Europe SmallCap Dividend Fund	$74.78	$164.5M

Frequently Asked Questions About XPH

What companies are XPH's competitors?: State Street SPDR S&P Pharmaceuticals ETF (XPH)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does XPH compare to its peers?: The peer comparison table on this page shows State Street SPDR S&P Pharmaceuticals ETF (XPH) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does XPH operate in?: State Street SPDR S&P Pharmaceuticals ETF (XPH) operates in the Asset Management industry within the Financial Services sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.